Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 268,912 |
|
|||||
| News | - | ||||||
| Day High | 227.90 | Low High |
|||||
| Day Low | 220.74 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -6.08 | -2.66% | 222.26 | 18:05:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 227.78 | 220.74 | 227.90 | 222.26 | 228.34 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,150 | 268,912 | $ 223.70 | $ 60,155,921 | - | 119.7604 - 322.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:31 | 8 | $ 220.55 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.43B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 245.08 | 248.63 | 220.74 | 234.41 | 285,832 | -22.82 | -9.31% |
| 1 Month | 261.96 | 268.22 | 220.74 | 246.97 | 360,939 | -39.70 | -15.15% |
| 3 Months | 226.14 | 299.98 | 168.2462 | 236.87 | 589,134 | -3.88 | -1.72% |
| 6 Months | 140.17 | 299.98 | 119.7604 | 216.99 | 478,634 | 82.09 | 58.56% |
| 1 Year | 270.00 | 322.67 | 119.7604 | 215.49 | 427,450 | -47.74 | -17.68% |
| 3 Years | 123.81 | 322.67 | 52.33 | 178.59 | 314,113 | 98.45 | 79.52% |
| 5 Years | 106.17 | 322.67 | 52.33 | 158.10 | 255,810 | 116.09 | 109.34% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
